For press requests, please contact Jimmy Wyderko at jwyderko@economicliberties.us or 301-221-7778.


DOJ Moves to Block UnitedHealth Group’s Acquisition of Amedisys to Protect Patients and Workers

November 12, 2024 — In response to news that the Department of Justice Antitrust Division has filed a lawsuit to challenge UnitedHealth Group’s acquisition of Amedisys, a home health and hospice care provider, the American Economic Liberties Project released the following statement.

FTC Bags Another Merger Trial Victory, Blocking $8.5 Billion Tapestry-Capri Deal

October 24, 2024 — Following news that the Federal Trade Commission (FTC) has successfully blocked the $8.5 billion Tapestry-Capri merger—with US District Judge Jennifer Rochon issuing a preliminary injunction after ruling the deal would significantly reduce competition in accessible-luxury handbag market—the American Economic Liberties Project released the following statement.  

As NY AG James Ramps Up Investigation into Capital One-Discover Deal, Federal Enforcers Should Follow Suit

October 24, 2024 — Following news that the New York State Attorney General Letitia James has asked the state supreme court to issue new subpoenas as part of an investigation Capital One proposed $35 billion acquisition of Discover Financial Services, the American Economic Liberties Project released the following statement.

CFPB’s Finalized Open Banking Rule Delivers Major Win for Consumers and Competition

October 22, 2024 — Following the Consumer Financial Protection Bureau’s finalization of a rule designed to facilitate enhanced consumer access to financial data and promote competition—through a provision of the Dodd-Frank Act known as Section 1033—the American Economic Liberties Project released the following statement.

Fixing the Hurricane-Induced IV Fluid Shortage

October 9, 2024 — Following the widespread devastation resulting from Hurricane Helene, which temporarily closed Baxter International’s intravenous (IV) solution factory in Marion, North Carolina that makes 60% of the nation’s supply, and B. Braun’s IV solution factory in Daytona Beach, Florida — which makes another 23% and lies in the path of Hurricane Milton — the American Economic Liberties Project released the following statement.